openPR Logo
Press release

Paclitaxel Injection Market Set for Rapid Growth and Trend, by 2019

Paclitaxel Injection Market Set for Rapid Growth and Trend,

Paclitaxel injection is a viscous anticancer drug, derived from the bark of the Pacific yew tree. Paclitaxel belongs to the group of drugs called antineoplastic. Paclitaxel injection is primarily used to treat various advanced stage cancer of the breast,ovaries, Kaposi sarcoma and non-small cell lung cancer. It is type of cytoskeletal medication that targets tubulin, which are a type of globular proteins.

Obtain Report Details @ http://www.transparencymarketresearch.com/paclitaxel-injection-market.html

The body cells that have defects in chromosome segregation, mitotic spindle assembly and cell division are treated Paclitaxel. Paclitaxel works by inhibiting the growth of cancer cells and by stabilizing the microtubule polymer. Paclitaxel injection should be administered under the supervision of an oncologists with experience in chemotherapy. Paclitaxel injection is used against some of the majormedical conditions-

Bladder cancer
Esophageal cancer
Cervical cancer
Endometrial cancer
Throat cancer
Non-small cell lung cancer
Kaposi's sarcoma
Stomach cancer
Testicular cancer
Fallopian tube cancer

Advantages of Paclitaxel injection such as immediate results, easy availability and better efficacy are some of the factors that are expected to drive the global Paclitaxel injection market. However, adverse effects such as allergy, leucopenia, blood clots, fever, diarrhea and weight loss are few drawbacksthat could hinder the growth of global Paclitaxel injection market. Moreover, stringent regulatory procedure could also act as the hindrance for the global market.

In the geographical perspective, North America is the largest market for Paclitaxel injection owing to the high incidence and prevalence rate of various cancers. The Asian-Pacific and European region arealso expected to be a potential markets for Paclitaxel injection owing to the increased number of cases of advanced stage cancer patients.

Fill the Form to Gain Deeper Insights on this Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2025

The companies involved in development and manufacturing of Paclitaxel injection are AbraxisBioScience Inc., Abbott Laboratories, Bristol-Myers Squibb, Fresenius Kabi Oncology Ltd., Onco Therapies Ltd., Strides Arcolab Ltd., Sagent Pharmaceuticals Inc. and Novasep, amongst others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us

Transparency Market Research
90 State Street, Suite 700,
Albany, NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Paclitaxel Injection Market Set for Rapid Growth and Trend, by 2019 here

News-ID: 716404 • Views:

More Releases from Transparency Market Research

Hand Dryer Market Size Forecast to USD 4.83 Billion by 2036 with Growing Focus on Hygiene and Sustainable Restroom Solutions - Analysis by Transparency Market Research
Hand Dryer Market Size Forecast to USD 4.83 Billion by 2036 with Growing Focus o …
Hand Dryer Market Outlook 2036 The global hand dryer market was valued at US$ 2.23 Billion in 2025 and is projected to reach US$ 4.83 Billion by 2036, expanding at a steady CAGR of 7.2% from 2026 to 2036. Market growth is driven by increasing emphasis on hygiene and sanitation, rising adoption in commercial infrastructure, and growing preference for eco-friendly and cost-effective hand drying solutions. 👉 Get sample market research report copy
Smart Glass Market Outlook 2036: Projected to Reach USD 35.8 Billion at 14.5% CAGR Driven by Energy-Efficient Buildings and Smart Infrastructure Adoption
Smart Glass Market Outlook 2036: Projected to Reach USD 35.8 Billion at 14.5% CA …
The global smart glass market was valued at US$ 8.1 Bn in 2025 and is projected to surge to US$ 35.8 Bn by 2036, expanding at a robust CAGR of 14.5% from 2026 to 2036. This nearly 4.4x growth over eleven years underscores the accelerating demand for intelligent glazing solutions across commercial, residential, automotive, and infrastructure sectors. North America emerged as the leading regional market in 2025, accounting for 29.8% of
Smoking Cessation and Nicotine De-Addiction Market to Reach USD 46.4 Bn by 2036, Driven by Rising Tobacco Burden and Digital Health Integration
Smoking Cessation and Nicotine De-Addiction Market to Reach USD 46.4 Bn by 2036, …
The global smoking cessation and nicotine de-addiction market is witnessing strong and sustained growth, fueled by intensifying public health initiatives and rising awareness about the long-term consequences of tobacco use. Valued at USD 15.5 Bn in 2025, the market is projected to expand at a robust CAGR of 10.5% from 2026 to 2036, reaching USD 46.4 Bn by 2036. Smoking cessation solutions encompass a wide range of products and services designed
3D Imaging Market to be Worth USD 266 Bn by 2036 - By Component Type / By End-Use Industry / By Region | U.S. • U.K. • India • Brazil
3D Imaging Market to be Worth USD 266 Bn by 2036 - By Component Type / By End-Us …
The global 3D imaging market is witnessing exponential growth, reflecting strong demand across healthcare, manufacturing, media, and industrial sectors. Valued at US$ 50 billion in 2025, the market is projected to reach US$ 266 billion by 2036, expanding at a robust CAGR of 18.2% from 2026 to 2036. Get a concise overview of key insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2743 This impressive trajectory highlights the rapid integration of advanced imaging

All 5 Releases


More Releases for Paclitaxel

Major Force in the Paclitaxel Injection Market 2025: Rising Incidence Of Breast …
How Will the Paclitaxel Injection Market Grow, and What Is the Projected Market Size? The paclitaxel injection market has seen rapid growth in recent years. It will increase from $6.02 billion in 2024 to $6.87 billion in 2025, at a CAGR of 14.1%. This growth is driven by clinical research, the rising incidence of cancer, greater patient awareness and education, and the globalization of the pharmaceutical industry. The paclitaxel injection market is
Paclitaxel Injection Global Market Report 2024 - Paclitaxel Injection Market Sha …
"The Business Research Company recently released a comprehensive report on the Global Paclitaxel Injection Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The paclitaxel injection
Global Albumin-bound Paclitaxel Market |Bound for Success: Navigating the Global …
Global Albumin-bound Paclitaxel Market Overview The Albumin-bound Paclitaxel market is a dynamic and multifaceted landscape that encompasses various products, services, and industries. It is characterized by intense competition, rapid innovation, changing consumer behavior, and evolving market trends. Businesses operating in the Albumin-bound Paclitaxel market need to have a deep understanding of the market dynamics, including its size, growth rate, customer preferences, competitive landscape, and regulatory environment. Market research reports providing a comprehensive
Paclitaxel HPLC Global Market Research Report 2025
Paclitaxel HPLC Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-chemical/paclitaxel-hplc-market/81094 The report firstly introduced the Paclitaxel HPLC basics: definitions, classifications, applications and market
Paclitaxel Global Market Research Report 2025
Paclitaxel Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/paclitaxel-market-3/81092 The report firstly introduced the Paclitaxel basics: definitions, classifications, applications and market overview; product
Global Paclitaxel Market Research Report 2017: Novasep, Samyang
In this report, the global Paclitaxel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Paclitaxel in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Fill